However, in this case, PD-1 is upregulated in the high-risk group, while PD-L1 is downregulated, suggesting a possible alteration in the immune evasion mechanism or a shift of the tumor toward a PD-L1-independent inhibitory pathway. Here, PDCD1 is linked to neoplasm.